Delivery Order SPE2DR25D7068-SPE2DR26F5BY8
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,032.11 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 2, 2025, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,998.92 by the Defense Logistics Agency on November 10, 2025, for the supply of Varivax vaccine with diluents. The contract is classified as a firm fixed price delivery order with an ultimate completion date of December 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation. As a child contract, this delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,059.07 delivery order for Varivax vaccine with diluents on December 3, 2025, with an ultimate completion date of December 24, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The vaccine delivery will be performed at...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,085.12 by the Defense Logistics Agency (DLA) for the supply of Varivax vaccine with diluents. The award, issued on July 7, 2025, with an ultimate completion date of July 28, 2025, carries a firm fixed price structure and represents a competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Varivax vaccine with diluents valued at $10,321.10 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain on June 30, 2025. The contract is set to complete by July 22, 2025, and represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,085.12 by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of May 12, 2025, and utilizes no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,321.10 on September 22, 2025, for the supply of Varivax vaccine with diluents to support federal medical procurement needs. This firm fixed price contract, which is expected to be completed by October 14, 2025, represents a non-competitive award issued by the Defense Logistics Agency's Medical Supply Chain division. The contract will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $3,006.21 and an ultimate completion date of January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,039.38 on November 28, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by December 19, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $124.3K by the Defense Logistics Agency on September 3, 2025, with completion targeted for September 24, 2025. The contract calls for the supply of Varivax vaccine with diluents under a firm fixed-price arrangement. This is a non-set-aside award, indicating the contract was competitively awarded. The delivery order is a child contract...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5BY8Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $14,170.66 by the Defense Logistics Agency for the supply of Varivax vaccine with diluents. The contract, awarded on December 15, 2025, carries a firm fixed price structure with an ultimate completion date of January 7, 2026. This is a non-set-aside competitive award to be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a prime vendor on the DLA Troop Support Medical contract, AmerisourceBergen Drug Corp serves as a critical supplier of pharmaceutical products and medical supplies to military healthcare systems and the Defense Health Agency. The Varivax vaccine delivery under this order supports federal immunization requirements across the military healthcare infrastructure. AmerisourceBergen's comprehensive pharmaceutical distribution capabilities and established competitive position with the DLA enable efficient fulfillment of specialized medical supply requirements such as this vaccine procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 12/14/25 |